{"doi":"10.1007/978-3-319-77736-8_2","title":"Glutamine Metabolism in Cancer","abstract":null,"journal":"Advances in Experimental Medicine and Biology","year":2018,"id":13965,"datarank":6.241687375347672,"base_score":5.564520407322694,"endowment":5.564520407322694,"self_citation_contribution":0.8346780610984041,"citation_network_contribution":5.407009314249268,"self_endowment_contribution":0.8346780610984041,"citer_contribution":5.407009314249268,"corpus_percentile":null,"corpus_rank":null,"citation_count":260,"citer_count":200,"citers_with_citation_signal":175,"citers_with_endowment":175,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":112395,"name":"Anne Le","orcid":null,"position":1,"is_corresponding":false},{"id":2857,"name":"Ting Li","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.564520407322694,"endowment":5.564520407322694,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29946773","pmcid":null,"openalex_id":"https://openalex.org/W2811124634","authors":[],"funders":[],"total_grants":0,"fwci":34.0704,"citation_percentile":0.99759904,"influential_citations":4,"citation_trend":[{"year":2018,"count":8},{"year":2019,"count":14},{"year":2020,"count":21},{"year":2021,"count":47},{"year":2022,"count":50},{"year":2023,"count":31},{"year":2024,"count":61},{"year":2025,"count":23},{"year":2026,"count":5}],"oa_status":"green","license":"http://www.springer.com/tdm","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9703266","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9703266","host_type":"repository"},{"url":"http://link.springer.com/content/pdf/10.1007/978-3-319-77736-8_2","host_type":"publisher"},{"url":"https://doi.org/10.1007/978-3-319-77736-8_2","host_type":"book series"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29946773","host_type":"repository"},{"url":"https://pubmed.ncbi.nlm.nih.gov/34014532","host_type":"repository"}],"fields_of_study":["Cancer, Hypoxia, and Metabolism","Amino Acid Enzymes and Metabolism","Cancer Research and Treatments","Medicine","Chemistry","Biology","Animals","Energy Metabolism","Glutamine","Humans","Neoplasms"],"mesh_terms":["Animals","Energy Metabolism","Glutamine","Humans","Neoplasms"],"keywords":["Glutaminolysis","Glutamine","Citric acid cycle","Metabolism","Pentose phosphate pathway","Cancer cell","Biochemistry","Cancer","Metabolic pathway","Warburg effect","Tricarboxylic acid","Biology","Cell cycle","Amino acid","Glutaminase","Glycolysis","Chemistry","Cell","Genetics","Glutamine Metabolism","Glutamine Addiction","Targeting Glutamine Metabolism","Targeting Amino Acid Synthesis","Transaminase Upregulation"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Affordable and clean energy"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.25017791.v1","title":"Additional file 1 of Glutamine metabolism-related genes and immunotherapy in nonspecific orbital inflammation were validated using bioinformatics and machine learning","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25017791","title":"Additional file 1 of Glutamine metabolism-related genes and immunotherapy in nonspecific orbital inflammation were validated using bioinformatics and machine learning","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25929186.v1","title":"Additional file 1 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25929186","title":"Additional file 1 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26617519.v1","title":"Additional file 1 of Bioinformatics and machine learning were used to validate glutamine metabolism-related genes and immunotherapy in osteoporosis patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26617519","title":"Additional file 1 of Bioinformatics and machine learning were used to validate glutamine metabolism-related genes and immunotherapy in osteoporosis patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26727196.v1","title":"Additional file 11 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727205.v1","title":"Additional file 14 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727205","title":"Additional file 14 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727199","title":"Additional file 12 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727199.v1","title":"Additional file 12 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727202.v1","title":"Additional file 13 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727202","title":"Additional file 13 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727193.v1","title":"Additional file 10 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727187","title":"Additional file 8 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727193","title":"Additional file 10 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727190.v1","title":"Additional file 9 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727187.v1","title":"Additional file 8 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727190","title":"Additional file 9 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727196","title":"Additional file 11 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727175.v1","title":"Additional file 5 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727178","title":"Additional file 6 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727184.v1","title":"Additional file 7 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727184","title":"Additional file 7 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26727172.v1","title":"Additional file 4 of Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-05-31T21:41:45.124250Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}